Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05587127 · ClinicalTrials.gov registry record · NA
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
A NA study of Dyspepsia and Functional Dyspepsia, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05587127: Recruiting NA study of Dyspepsia and Functional Dyspepsia, sponsored by Massachusetts General Hospital.
NCT05587127 is a NA study of Dyspepsia and Functional Dyspepsia that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 50 participants, below the 72-participant average among 11 other Dyspepsia trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05587127, a NA study of Dyspepsia and Functional Dyspepsia, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized controlled trial of an exposure-based behavioral treatment (CBT) in adults with functional dyspepsia who meet criteria for avoidant/restrictive food intake disorder (ARFID) with weight loss.
Primary Outcome
At the end of the study, we will calculate the percentage of participants who consent to initiate the study from the total who are offered.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-11-30 |
| Est. Completion | 2027-05 |
| Phase | NA |
What NCT05587127 shows while recruiting
NCT05587127 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 72-participant average among 11 other Dyspepsia trials with a reported enrollment target (31% lower).
The record links to 8 conditions, with Dyspepsia appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.
NCT05587127 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05587127 about?
NCT05587127 is a clinical study titled "Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia". Randomized controlled trial of an exposure-based behavioral treatment (CBT) in adults with functional dyspepsia who meet criteria for avoidant/restrictive food intake disorder (ARFID) with weight loss.
What is the current status of trial NCT05587127?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-11-30. Estimated completion is 2027-05.
What conditions does trial NCT05587127 study?
This clinical trial studies the following conditions: Dyspepsia, Functional Dyspepsia, Cognitive Behavioral Therapy, Avoidant Restrictive Food Intake Disorder, Feeding and Eating Disorders.
What interventions are being tested in trial NCT05587127?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05587127?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05587127 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyspepsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05587127's enrollment target sits among peer trials
50 8th of 11 higher than 3 of 11 other Dyspepsia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dyspepsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Visible Abdominal Distension
RECRUITING · NA
-
Zypan Functional Dyspepsia
RECRUITING · NA
-
High Resolution Gastric Mapping and Gastroduodenal Manometry
RECRUITING · NA
-
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
RECRUITING · NA
-
Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility
ACTIVE NOT RECRUITING · NA
-
Melatonin in Pediatric FD Population
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI